# ClinicalTrials.gov record NCT01841359

> PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct01841359-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-06-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01841359-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01841359-pramlintide-v1.json
- Content SHA-256: `4c0e67e962cceb98902e80ab71b63601978d4cb758fd2ed0d2cbd941b7bf119e`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01841359 ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

## Sources

<a id="source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c"></a>
- **ClinicalTrials.gov record NCT01841359 · retained source version 2023-06-29:3d0df998d96cd592ddfaec977b4f372b717cf9572637d643da8a39fc2d05e3fc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01841359) (`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01841359." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01841359-pramlintide-v1.json SHA-256: 4c0e67e962cceb98902e80ab71b63601978d4cb758fd2ed0d2cbd941b7bf119e.